• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Not Available].

作者信息

Ye Zhikang, Wang Ying, Colunga-Lozano Luis Enrique, Prasad Manya, Tangamornsuksan Wimonchat, Rochwerg Bram, Yao Liang, Motaghi Shahrzad, Couban Rachel J, Ghadimi Maryam, Bala Malgorzata M, Gomaa Huda, Fang Fang, Xiao Yingqi, Guyatt Gordon H

机构信息

Département de Health Research Methods, Evidence and Impact (Ye, Tangamornsuksan, Rochwerg, Guyatt, Colunga-Lozano, Yao, Motaghi, Fang, Xiao), Université McMaster, Hamilton, Ont.; département de pharmacie (Wang), hôpital de Chaoyang à Beijing, Capital Medical University, Beijing (Chine); département de médecine clinique (Colunga-Lozano), centre des sciences de la santé, université de Guadalajara, Guadalajara (Mexique); département de médecine Communautaire (Prasad), North DMC Medical College, New Delhi (Inde); Faculté de médecine et de santé publique (Tangamornsuksan), HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok (Thaïlande); département de médecine (Rochwerg); DeGroote Institute for Pain Research and Care (Couban), Université McMaster, Hamilton, Ont.; département de pharmacie clinique (Ghadimi), Faculté de pharmacie, Tehran University of Medical Sciences, Téhéran (Iran); chaire d'épidémiologie et de médecine préventive (Bala), École de médecine de l'Université Jagellonne, Cracovie (Pologne); département de biostatistique (Gomaa), High institute of Public Health, Alexandria University, Alexandrie (Égypte); Centre d'information sur les médicaments (Gomaa), Tanta Chest Hospital, ministère de la Santé et des Populations, Égypte; Clinical Medicine College of Acupuncture, Moxibustion and Rehabilitation (Fang), Guangzhou University of Chinese Medicine, Guangdong (Chine); West China School of Nursing (Xiao), West China Hospital, Sichuan University (Chine).

Département de Health Research Methods, Evidence and Impact (Ye, Tangamornsuksan, Rochwerg, Guyatt, Colunga-Lozano, Yao, Motaghi, Fang, Xiao), Université McMaster, Hamilton, Ont.; département de pharmacie (Wang), hôpital de Chaoyang à Beijing, Capital Medical University, Beijing (Chine); département de médecine clinique (Colunga-Lozano), centre des sciences de la santé, université de Guadalajara, Guadalajara (Mexique); département de médecine Communautaire (Prasad), North DMC Medical College, New Delhi (Inde); Faculté de médecine et de santé publique (Tangamornsuksan), HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok (Thaïlande); département de médecine (Rochwerg); DeGroote Institute for Pain Research and Care (Couban), Université McMaster, Hamilton, Ont.; département de pharmacie clinique (Ghadimi), Faculté de pharmacie, Tehran University of Medical Sciences, Téhéran (Iran); chaire d'épidémiologie et de médecine préventive (Bala), École de médecine de l'Université Jagellonne, Cracovie (Pologne); département de biostatistique (Gomaa), High institute of Public Health, Alexandria University, Alexandrie (Égypte); Centre d'information sur les médicaments (Gomaa), Tanta Chest Hospital, ministère de la Santé et des Populations, Égypte; Clinical Medicine College of Acupuncture, Moxibustion and Rehabilitation (Fang), Guangzhou University of Chinese Medicine, Guangdong (Chine); West China School of Nursing (Xiao), West China Hospital, Sichuan University (Chine)

出版信息

CMAJ. 2020 Nov 23;192(47):E1571-E1584. doi: 10.1503/cmaj.200645-f.

DOI:10.1503/cmaj.200645-f
PMID:33229355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7721260/
Abstract
摘要

相似文献

1
[Not Available].[无可用内容]。
CMAJ. 2020 Nov 23;192(47):E1571-E1584. doi: 10.1503/cmaj.200645-f.
2
Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.儿童系统性红斑狼疮合并急性呼吸窘迫综合征及 COVID-19。
Lupus. 2021 Apr;30(5):836-839. doi: 10.1177/0961203321989791. Epub 2021 Jan 28.
3
The Role of Glucocorticoids in the Management of COVID-19.糖皮质激素在 COVID-19 管理中的作用。
Horm Metab Res. 2021 Jan;53(1):9-15. doi: 10.1055/a-1300-2550. Epub 2020 Nov 18.
4
A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.《一例使用甲泼尼龙治疗 SARS-CoV-2 德尔塔变异株所致儿童 Lennox-Gastaut 综合征并严重急性呼吸窘迫综合征的病例报告》。
J Korean Med Sci. 2022 Mar 14;37(10):e82. doi: 10.3346/jkms.2022.37.e82.
5
Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?芦可替尼对有急性呼吸窘迫综合征(ARDS)风险的新型冠状病毒肺炎(COVID-19)感染患者是否有效?
Ann Hematol. 2020 Jul;99(7):1675-1676. doi: 10.1007/s00277-020-04067-6. Epub 2020 May 14.
6
Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.通过系统生物学方法和基于五个药物设计规范的 DNN-DTI 模型,重新利用多种分子药物治疗 COVID-19 相关急性呼吸窘迫综合征和非病毒性急性呼吸窘迫综合征。
Int J Mol Sci. 2022 Mar 26;23(7):3649. doi: 10.3390/ijms23073649.
7
AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.抗 miRNA:治疗 COVID-19 细胞因子风暴的新策略。
Cytokine Growth Factor Rev. 2021 Apr;58:111-113. doi: 10.1016/j.cytogfr.2020.09.001. Epub 2020 Sep 9.
8
Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury.将 fostamatinib 重新用于治疗 SARS-CoV-2 诱导的急性肺损伤。
Cell Rep Med. 2020 Nov 17;1(8):100145. doi: 10.1016/j.xcrm.2020.100145.
9
Is dexamethasone an effective treatment for severe COVID-19 patients: Journal Club review.地塞米松对重症 COVID-19 患者是否为有效治疗方法:期刊俱乐部综述。
CJEM. 2021 Mar;23(2):159-161. doi: 10.1007/s43678-020-00033-3. Epub 2021 Jan 4.
10
COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan.多发性骨髓瘤患者的新型冠状病毒肺炎感染:来自维尔茨堡和武汉的德中经验
Ann Hematol. 2021 Mar;100(3):843-846. doi: 10.1007/s00277-020-04184-2. Epub 2020 Jul 18.

本文引用的文献

1
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.与 SARS-CoV-2 感染住院非重症患者病毒持续排出相关因素及洛匹那韦/利托那韦治疗的影响。
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.00799-2020. Print 2020 Jul.
2
Adjuvant corticosteroid therapy for critically ill patients with COVID-19.COVID-19重症患者的辅助性皮质类固醇治疗
Crit Care. 2020 May 19;24(1):241. doi: 10.1186/s13054-020-02964-w.
3
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline.2019年非重症和重症冠状病毒病患者的治疗:循证指南
CMAJ. 2020 May 19;192(20):E536-E545. doi: 10.1503/cmaj.200648. Epub 2020 Apr 29.
4
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
5
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.皮质类固醇治疗冠状病毒感染患者的效果:系统评价和荟萃分析。
J Infect. 2020 Jul;81(1):e13-e20. doi: 10.1016/j.jinf.2020.03.062. Epub 2020 Apr 10.
6
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
7
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
8
On the use of corticosteroids for 2019-nCoV pneumonia.关于皮质类固醇在2019新型冠状病毒肺炎中的应用。
Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
10
Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study.皮质类固醇治疗对流感相关急性呼吸窘迫综合征临床结局的影响:一项全国性多中心研究
Ann Intensive Care. 2020 Feb 27;10(1):26. doi: 10.1186/s13613-020-0642-4.